About
Accunea is a point-of-care diagnostics company which is developing RenoSure, a medical device capable of detecting critical changes in transplant organ function in real-time, both before and after transplantation. This will enable closer monitoring of kidney transplant patients both pre- and post-operatively to ensure every patient receives a kidney in the best possible condition, and recovers without complications. RenoSure is assisted by AI software which enables early warnings from trend analysis, as well as enabling anonymised data aggregation and analytics for both individual and population-level health.
Technologies
Gmail
Google Apps
Microsoft Office 365
Google Cloud Hosting
Google Analytics
Wix
Mobile Friendly
Google Tag Manager
YouTube
Varnish
IoT
Keywords
diagnostics
bioengineering
transplantation
kidney function
kidney injury
monitoring
biosensing
medical device
medical equipment manufacturing
risk assessment
medical equipment and supplies manufacturing
organ condition monitoring
services
organ discard reduction
clinical insights
metabolic biomarkers
ai system
real-time biomarkers
hypothermic storage monitoring
biomarker monitoring
clinical biomarker support
clinical decision support
b2b
medical devices
bloodless sampling
continuous sampling
pre- and post-transplant monitoring
microfluidic lab-on-chip
metabolism analysis
normothermic reperfusion
Company Information
-
Employees 7
-
Founded 2017
Location
1 Comberton Road, Kidderminster, England, United Kingdom, DY10 1UA
